Nichols David Wayne 4
4 · Magenta Therapeutics, Inc. · Filed Sep 16, 2021
Insider Transaction Report
Form 4
Nichols David Wayne
Chief Technical Officer
Transactions
- Award
Common Stock
2021-09-14+20,000→ 20,000 total
Footnotes (1)
- [F1]On April 19, 2021, the reporting person was granted 40,000 restricted stock units. The restricted stock units vest in two equal installments subject to the achievement of certain performance milestones related to the issuer's business plans. The first performance milestone was achieved, resulting in vesting of 20,000 restricted stock units and the corresponding issuance of 20,000 shares of issuer common stock.